Also in this section

• News Home
• News Archive
• Patients at high risk of a heart attack or stroke are under treated
• A 360 degree view of healthcare innovation
• Back care doesn't measure up
• New research: time for Australia to target salt
• New recommendations to enhance registration processes of drugs for neglected diseases in Africa
• Chinese delegation visit to The George
• Salt Targets for Packaged and Restaurant Foods
• New Australian research highlights gaps in treating cardiovascular risks
• The polypill: addressing cardiovascular risk in Indigenous Australians
• Food policy for good health, learning from the UK
• Coffee and tea protects against diabetes
• US$3billion spent on neglected disease R&D in 2008
• Call for high salt warning on Angry Beef Burger
• Self harm: major road safety issue for young drivers
• New China research Center to address threat of chronic disease
• New research center to address threat of chronic disease in China
• Research reveals uncertainty around effectiveness of common treatment used in high-risk kidney patients.
• Introducing the Young Driver Factbase
• Providing essential information for physiotherapists
• Staff profile: Professor Lijing Yan - The George Institute, China
• Mild traumatic brain injury high among non-professional rugby players
• Research findings confirm aggressive kidney treatments not justified
• Mandawuy Yunupingu discusses his battle with chronic kidney disease
• Is paracetamol effective for back pain?
• Major health initiatives receive funding from Australia's National Health and Medical Research Council
• Four out of 10 chronic back pain sufferers will recover within a year
• Association found between school safety program and reduced risk of crash
• Back Pain Unlikely Symptom Of Serious Disease
• Rural Roads Dangerous For Young Drivers
• Many Australians At Risk Of Cardiovascular Disease Are Not Receiving Best Practice Care
• New analysis confirms benefits for type 2 diabetes

Indigenous Health Philanthropic Opportunities

The Kanyini Collaboration

Kanyini is a term used by Pitjantjatjara and Pintubi/Luritja and can be translated as ‘to have, to hold and to care’. The Kanyini collaboration is designed to tackle the rate of premature death among Indigenous Australians due to cardiovascular disease, diabetes and chronic kidney disease. Kanyini aims to clarify and break down these barriers working with Aboriginal Community Controlled Health Services to produce locally meaningful solutions, using a blend of research and communications programs.

Funding for the Kanyini collaboration will allow researchers to extend research, and produce education and training materials to help health providers improve communications and encourage Indigenous communities to access available health care.

Chronic disease prevention programs

The polypill, is a low-cost innovative treatment that combines several medications in one single tablet. This treatment will help reduce the cost and complexity of reducing several major risk factors of cardiovascular disease and be of particular value for low-income communities among patients who have a high risk of heart attack, stroke

Support for the polypill project will enable this research to be undertaken on a broader scale across the wider Indigenous community. This study will establish the true benefits of the polypill among a population who could significantly benefit from a low cost, risk reduction therapy

Development of ‘whole of community’ initiatives in partnership with the Fitzroy Valley community, to address the health and safety factors driving poor health and social outcomes. Fitzroy Valley may then be used as a ‘real world’ model of sustainable partnership for the implementation of a range of ‘closing the gap’ interventions.

Backing further support for the Fitzroy Valley community will implement far-reaching health and safety changes after the success of a take - away alcohol ban and its positive impacts.

More information regarding Indigenous and kidney disease programs